In a report released today, Ryan Krueger from KBW maintained a Buy rating on Metlife (MET – Research Report), with a price target of $87.00. The company’s shares closed yesterday at $71.88.
Krueger covers the Financial sector, focusing on stocks such as Globe Life, Voya Financial, and CNO Financial. According to TipRanks, Krueger has an average return of 13.0% and a 70.99% success rate on recommended stocks.
Metlife has an analyst consensus of Strong Buy, with a price target consensus of $83.88.
The company has a one-year high of $74.68 and a one-year low of $47.75. Currently, Metlife has an average volume of 3.3M.
Based on the recent corporate insider activity of 116 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MET in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Metlife (MET) Company Description:
Headquartered in New York, MetLife, Inc. is among the largest global providers of insurance and financial services to individual and institutional customers. It offers life insurance, annuities, employee benefits and asset management services. The company operates through the following segments: U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings.
